Physician profile
John E Kehoe
NPI 1669714309
$1,432.28
in general payments reported to CMS, 2019-2025
12 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $65.29 · 2024: $161 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Travel and Lodging: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.26 |
| Travel and Lodging | $274.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $521.87 | 2025 | |
| Sumitomo Pharma America, INC. | $148.59 | 2025 | Gemtesa, Orgovyx |
| Amgen INC. | $135.95 | 2025 | Repatha |
| Abbvie INC. | $121.71 | 2025 | |
| Urogen Pharma, INC. | $111.51 | 2024 | |
| Boston Scientific Corporation | $109.72 | 2022-2025 | General - Erectile Dysfunction |
| Astellas Pharma US INC | $85.70 | 2025 | Xtandi |
| Novartis Pharmaceuticals Corporation | $71.43 | 2024-2025 | |
| Medtronic, INC. | $63.19 | 2024-2025 | Interstim |
| Janssen Biotech, INC. | $29.60 | 2025 | Erleada |
| Antares Pharma, INC. | $17.75 | 2025 | Xyosted |
| Axonics, INC. | $15.26 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kehoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.